Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats

Lupulesco, 1978, Ehnancement of carcinogenesis by prostaglandins, Nature, 272, 634, 10.1038/272634a0

Prescott, 2000, Cyclooxygenase-2 and carcinogenesis, Biochim Biophys Acta, 1470, M69

Dempke, 2001, Cyclooxygenase-2: a novel target for cancer chemotherapy?, J Cancer Res Clin Oncol, 127, 411, 10.1007/s004320000225

Kawamori, 1998, Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis, Cancer Res, 58, 409

Grubbs, 2000, Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female fisher-344 rats, Cancer Res, 60, 5599

Pentland, 1999, Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition, Carcinogenesis, 10, 1939, 10.1093/carcin/20.10.1939

Harris, 2000, Chemoprevention of breast cancer in rats by celecoxib a cyclooxygenase 2 inhibitor, Cancer Res, 60, 2101

Steinbach, 2000, The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis, N Engl J Med, 342, 1946, 10.1056/NEJM200006293422603

Kern, 2002, Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells, Hepatology, 36, 885, 10.1053/jhep.2002.36125

Masferrer, 2000, Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors, Cancer Res, 60, 1306

Maier, 2004, Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells, Biochem Pharmacol, 67, 1469, 10.1016/j.bcp.2003.12.014

Han, 2004, Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest, Cancer Res, 64, 1369, 10.1158/0008-5472.CAN-03-1086

Wong, 2003, Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer, Oncogene, 22, 1189, 10.1038/sj.onc.1206234

Masferrer, 1996, Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract, Gastroenterol Clin N Am, 25, 363, 10.1016/S0889-8553(05)70252-1

Semple-Roberts, 1987, Alternative methods of selecting rat hepatocellular nodules resistant to 2-acetylaminofluorene, Int J Cancer, 40, 643, 10.1002/ijc.2910400512

Rutenburg, 1969, Histochemical and ultrastructural demonstration γ-glutamil transpeptidase activity, J Histochem Citochem, 17, 517, 10.1177/17.8.517

Mayer, 1990, 7-Alkoxyquinolines: new fluorescent substrates for cytochrome P450 monooxygenases, Biochem Pharmacol, 40, 1645, 10.1016/0006-2952(90)90467-Y

Blobel, 1996, Nuclei from rat liver: isolation method that combines purity with high yield, Science, 154, 1662, 10.1126/science.154.3757.1662

Fleischer, 1974, Subcellular fractionation of rat liver, Methods Enzymol, 31, 6, 10.1016/0076-6879(74)31005-1

Reddy, 2000, Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis, Cancer Res, 60, 293

Hendrich, 1987, Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis, Cancer Metastasis Rev, 6, 155, 10.1007/BF00052847

Tsuchida, 1992, Glutathione transferases and cancer, Crit Rev Biochem Mol Biol, 27, 337, 10.3109/10409239209082566

Kelman, 1997, PCNA: structure, functions and interactions, Oncogene, 14, 629, 10.1038/sj.onc.1200886

Scholzen, 2000, The Ki-67 protein: from the known and the unknown, J Cell Physiol, 182, 311, 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9

Bharti, 2002, Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization, Ann NY Acad Sci, 973, 392, 10.1111/j.1749-6632.2002.tb04671.x

Rizzi, 1997, Beta-carotene inhibits persistent and stimulates remodeling gamma GT-positive preneoplastic lesions during early promotion of hepatocarcinogenesis, Int J Vitam Nutr Res, 67, 415

Carrasco-Legleu, 2004, Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay, Int J Cancer, 108, 488, 10.1002/ijc.11595

Grosch, 2001, COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib, FASEB J, 15, 2742, 10.1096/fj.01-0299fje

Williams, 2000, Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models, Cancer Res, 60, 6045

Cheng, 2002, NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines, Int J Cancer, 99, 755, 10.1002/ijc.10409

Kundu, 2002, Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycle, Breast Cancer Res Treat, 76, 57, 10.1023/A:1020224503335

Zeini, 2004, Simultaneous abrogation of NOS-2 and COX-2 activities is lethal in partially hepatectomised mice, J Hepatol, 40, 926, 10.1016/j.jhep.2004.02.016

Won, 2004, Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms, Carcinogenesis, 25, 1449, 10.1093/carcin/bgh151

Joyce, 2001, NF-kappaB and cell-cycle regulation: the cyclin connection, Cytokine Growth Factor Rev, 12, 73, 10.1016/S1359-6101(00)00018-6

Koga, 2001, Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazoneinduced cell-cycle arrest in human hepatoma cell lines, Hepatology, 33, 1087, 10.1053/jhep.2001.24024

Planagumà, 2004, The selective cyclooxygenase-2 inhibitor SC-236 reduces experimental liver fibrosis by inactivating kupffer cells and acting as a peroxisome proliferator-activated receptor gamma ligand, J Hepatol, 40, 8, 10.1016/S0168-8278(04)90021-9